Total: $745.37M |
||||
Company | Type Of | Number Of Shares, Units Or Warrants | Amount | Investors; Placement Agents; Details |
Aastrom | Private | 1.05S | $1.5 | Aastrom placed 689,655 shares with Radyr Group Investments, raising $1M, and another 364,407 shares with Rochelle SA, raising $500,000 (7/31) |
Bioniche Life | Private | N/A | C$4 (US$2.63) | Bioniche finished the second tranche of its C$10M (US$6.6M) financing, raising US$2.63M (7/5) |
COR | Private | N/A | $50 | COR sold an additional $50M principal amount of 4.5% convertible senior notes, due 2006, to cover overallotments in its $250M private placement to institutional investors (7/11) |
Esperion | Private | 3.2S | $24 | Esperion agreed to sell $24M of stock privately; Robertson Stephens Inc. acted as placement agent, and U.S. Bancorp Piper Jaffray served as financial adviser (7/26) |
Generex | Private | N/A | US$11 | Generex closed two separate private placements, raising US$11M; the placement consisted of the sale of common stock to accredited investors, who also received a three-year warrant for each share purchased (7/9) |
Genset SA | Equity | N/A | ¿ | Genset entered an agreement under which SG Cowen will purchase up to EUR50M (US$43.8M) of Genset stock over two years (7/24) |
ICN | Private | N/A | $525 | ICN raised $525M through the placement of 6.5% convertible subordinated notes, due 2008; the notes are convertible into common shares at about $34.25 per share (7/18) |
Isotechnika | Private | 5.7W | C$25.08 (US$16.24) | Isotechnika raised US$16.24M in an offering of 5.7M warrants to a syndicate of investment dealers led by TD Securities Inc. (7/20) |
LifeCell | Private | 3.125S and 1.75W | $6 | LifeCell entered into purchase agreements with selected accredited institutional investors for the private placement of up to 2.135M shares and warrants to purchase 1.75M shares (7/2) |
MacroChem | Private | 1.56S | $10.1 | MacroChem raised $10.1M in a private placement to institutional investors, selling about 1.56M shares at $6.48 each; investors also received five-year warrants to buy 313,209 shares at $8.995 per share (7/16) |
Matritech Inc. | Private | 0.33S | $1 | Matritech sold 331,532 shares to Acqua Wellington North American Equities Fund Ltd., raising $1M (7/6) |
Microcide | Private | ND | $60 | The new firm raised $60M in private equity funding; Prospect Venture Partners LP, New Enterprise Associates and Schroder Ventures conducted the transaction (7/30) |
Penwest | Private | 2.4S | $30 | Penwest sold 2.4M shares of common stock to institutional and other accredited investors for $30M (7/10) |
Protein | Private | N/A | $1.2 | Protein Polymer raised about $1.2M in the placement; investors include Johson & Johnson Development Corp. and previous shareholders (7/25) |
ViroLogic | Private | 3.2W | $6.7 | ViroLogic closed the first segment of a $16.3M private placement, pulling in about $6.7M; the company issued 6% convertible preferred stock, and purchasers also will receive warrants to purchase 3.2M shares (7/3) |
Notes: |
||||
# Unless otherwise indicated, shares are traded on the Nasdaq exchange. |
||||
@ Dates refer to the date of the press release. |
||||
N/A = Not available or reported. |
||||
NYSE = New York Stock Exchange; OTC BB = Over the Counter Bulletin Board; TSE = Toronto Stock Exchange |
||||
